Disruption of HLA-DR raft, deregulations of Lck-ZAP-70-Cbl-b cross-talk and miR181a towards T cell hyporesponsiveness in leprosy
- PMID: 21453975
- DOI: 10.1016/j.molimm.2011.02.012
Disruption of HLA-DR raft, deregulations of Lck-ZAP-70-Cbl-b cross-talk and miR181a towards T cell hyporesponsiveness in leprosy
Abstract
Leprosy, a chronic human disease, results from infection of Mycobacterium leprae. Defective CMI and T cell hyporesponsiveness are the major hallmark of M. leprae pathogenesis. The present study demonstrates immunological-deregulations that eventually lead to T cell anergy/hyporesponsiveness in M. lepare infection. We firstly, evaluated the membrane fluidity and antigen-presenting-lipid-raft (HLA-DR) on macrophages of leprosy patients using fluorescence anisotropy and confocal microscopy, respectively. Increased membrane fluidity and raft-out localizations of over-expressed HLA-DR towards BL/LL pole are pinpointed as major defects, may be leading to defective antigen presentation in leprosy. Furthermore, altered expression and localization of Lck, ZAP-70, etc. and their deregulated cross talks with negative regulators (CD45, Cbl-b and SHP2) turned out to be the major putative reason(s) leading to T cell hyporesponsiveness in leprosy. Deregulations of Lck-ZAP-70 cross-talk in T cells were found to be associated with cholesterol-dependent-dismantling of HLA-DR rafts in macrophages in leprosy progression. Increased molecular interactions between Cbl-b and Lck/ZAP-70 and their subsequent degradation via ubiquitinization pathway, as result of high expression of Cbl-b, were turned out to be one of the principal underlying reason leading to T cell anergy in leprosy patients. Interestingly, overexpression of SHP2 due to gradual losses of miR181a and subsequent dephosphorylation of imperative T cell signaling molecules were emerged out as another important reason associated with prevailing T cell hyporesponsiveness during leprosy progression. Thus, this study for the first time pinpointed overexpression of Cbl-b and expressional losses of miR-181 as important hallmarks of progression of leprosy.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Similar articles
-
Th3 immune responses in the progression of leprosy via molecular cross-talks of TGF-β, CTLA-4 and Cbl-b.Clin Immunol. 2011 Nov;141(2):133-42. doi: 10.1016/j.clim.2011.06.007. Epub 2011 Jul 1. Clin Immunol. 2011. PMID: 21807564
-
Regulation of T cell development by c-Cbl: essential role of Lck.Int Immunol. 2015 May;27(5):245-51. doi: 10.1093/intimm/dxu105. Epub 2014 Dec 4. Int Immunol. 2015. PMID: 25477210 Free PMC article.
-
Mycobacterial antigen(s) induce anergy by altering TCR- and TCR/CD28-induced signalling events: insights into T-cell unresponsiveness in leprosy.Mol Immunol. 2010 Feb;47(5):943-52. doi: 10.1016/j.molimm.2009.11.009. Epub 2009 Dec 16. Mol Immunol. 2010. PMID: 20018378
-
HLA and leprosy in the pre and postgenomic eras.Hum Immunol. 2006 Jun;67(6):439-45. doi: 10.1016/j.humimm.2006.03.009. Epub 2006 Apr 3. Hum Immunol. 2006. PMID: 16728267 Review.
-
The role of competing mechanisms on Lck regulation.Immunol Res. 2020 Oct;68(5):289-295. doi: 10.1007/s12026-020-09148-2. Epub 2020 Aug 14. Immunol Res. 2020. PMID: 32794043 Review.
Cited by
-
Identification of potential biomarkers of leprosy: A study based on GEO datasets.PLoS One. 2024 May 13;19(5):e0302753. doi: 10.1371/journal.pone.0302753. eCollection 2024. PLoS One. 2024. PMID: 38739634 Free PMC article.
-
ncRNAs: an unexplored cellular defense mechanism in leprosy.Front Genet. 2023 Dec 4;14:1295586. doi: 10.3389/fgene.2023.1295586. eCollection 2023. Front Genet. 2023. PMID: 38116294 Free PMC article. Review.
-
Leprosy: A Review of Epidemiology, Clinical Diagnosis, and Management.J Trop Med. 2022 Jul 4;2022:8652062. doi: 10.1155/2022/8652062. eCollection 2022. J Trop Med. 2022. PMID: 35832335 Free PMC article. Review.
-
Non-Coding RNAs in the Etiology and Control of Major and Neglected Human Tropical Diseases.Front Immunol. 2021 Oct 19;12:703936. doi: 10.3389/fimmu.2021.703936. eCollection 2021. Front Immunol. 2021. PMID: 34737736 Free PMC article. Review.
-
E3 Ubiquitin Ligases as Immunotherapeutic Target in Atherosclerotic Cardiovascular Disease.Front Cardiovasc Med. 2020 Jun 5;7:106. doi: 10.3389/fcvm.2020.00106. eCollection 2020. Front Cardiovasc Med. 2020. PMID: 32582770 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous